33
Participants
Start Date
September 30, 2000
Primary Completion Date
August 31, 2004
Study Completion Date
October 31, 2007
Trastuzumab
Paclitaxel
Carboplatin
Gemcitabine
The University of Michigan Comprehensive Cancer Center, Ann Arbor
California City of Hope National Medical Group, Duarte
USC/Norris Comprehensive Cancer Center, Los Angeles
U.C. Davis Medical Center, Sacramento
University of Colorado, Aurora
Wayne State University, Detroit
Roswell Park Cancer Institute, Buffalo
Columbia Presbyterian Medical Center, New York
Weill Medical College of Cornell University, New York
University of Pennsylvania Cancer Center, Philadelphia
University of Pittsburgh Cancer Institute, Pittsburgh
Collaborators (1)
Genentech, Inc.
INDUSTRY
University of Michigan Rogel Cancer Center
OTHER